We have previously proposed a cell-based screening method 'EGFinduced (epidermal growth factor) filopodium protrusion assay' to identify mitochondrial electron transport inhibitors or glycolysis inhibitors. Filopodia are spike-like cell membrane projections that contribute to tumor metastasis. Previously, we have reported that mitochondrial electron transport inhibition resulted in the inhibition of EGF-induced filopodium protrusion in human adenocarcinoma A431 cells only when their glycolytic pathways were restricted. 1 By using the inhibition of filopodium protrusion as an indicator, we identified napyradiomycin A1 (Figure 1a; isolated from Streptomyces antimycoticus NT17), 2 which was previously identified as an antibacterial antibiotic, 3 as a candidate of mitochondrial electron transport inhibitor. A431 cells were treated with napyradiomycin A1 with or without 10 mM 2-deoxy-D-glucose (Sigma-Aldrich, St Louis, MO, USA) for 30 min, followed by 30 ng ml À1 EGF (Sigma-Aldrich) stimulation and observation under a microscope. As shown in Figure 1b, 20 mM napyradiomycin A1 inhibited EGF-induced filopodium protrusion in A431 cells only in the presence of the glycolytic enzyme hexokinase inhibitor 2-deoxy-D-glucose. Mitochondrial electron transport inhibitor rotenone (Sigma-Aldrich) also inhibited filopodium protrusion only in the presence of 2-deoxy-D-glucose. Furthermore, it was reported that co-treatment with a mitochondrial electron transport inhibitor and a glycolytic inhibitor markedly decreased intracellular ATP levels. 1 We then tested whether napyradiomycin A1 decreased ATP levels in A431 cells in which glycolytic pathways were restricted. As intracellular ATP levels were not affected by EGF stimulation (data not shown), we measured intracellular ATP levels under the condition where A431 cells were treated with napyradiomycin A1 with or without 10 mM 2-deoxy-D-glucose for 30 min in the absence of EGF. After incubation, intracellular ATP levels were measured using a Cell Titer-Glo Luminescent Cell Viability Assay Kit (Promega, Madison, WI, USA) with a luminometer (Wallac; Perkin-Elmer, Waltham, MA, USA). As shown in Figure 1c, napyradiomycin A1 treatment did not decrease cellular ATP levels; however, 20 mM napyradiomycin A1 markedly decreased cellular ATP levels in the presence of 2-deoxy-D-glucose in A431 cells. Furthermore, ATP levels in HeLa cells also decreased under co-treatment with napyradiomycin A1 and 2-deoxy-D-glucose (data not shown). These results suggested that napyradiomycin A1 inhibited mitochondrial electron transport in cancer cells.Next, we examined whether napyradiomycin A1 actually inhibited mitochondrial electron transport in vitro by using submitochondrial particles (SMP) obtained from the bovine heart. In order to prepare SMP, bovine hearts were homogenized in MSH buffer (210 mM mannitol, 70 mM sucrose, 1 mM DTT, 1 mM EGTA, 0.1% BSA and 10 mM HEPES pH 7.4) with a Potter-Elvehjem homogenizer (Nippon genetics, Tokyo, Japan). Homogenates were centrifuged at 1000 g for 10 min, and the res...